A detailed history of Grimes & Company, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Grimes & Company, Inc. holds 606 shares of MCK stock, worth $349,474. This represents 0.01% of its overall portfolio holdings.

Number of Shares
606
Previous 599 1.17%
Holding current value
$349,474
Previous $349,000 14.33%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$479.06 - $630.38 $3,353 - $4,412
7 Added 1.17%
606 $299,000
Q2 2024

Jul 22, 2024

BUY
$518.81 - $607.81 $9,857 - $11,548
19 Added 3.28%
599 $349,000
Q1 2024

Apr 17, 2024

SELL
$473.42 - $539.26 $946 - $1,078
-2 Reduced 0.34%
580 $311,000
Q4 2023

Jan 24, 2024

BUY
$437.42 - $470.64 $874 - $941
2 Added 0.34%
582 $269,000
Q3 2023

Oct 19, 2023

BUY
$402.4 - $446.42 $2,012 - $2,232
5 Added 0.87%
580 $252,000
Q2 2023

Jul 19, 2023

SELL
$354.01 - $427.31 $708 - $854
-2 Reduced 0.35%
575 $245,000
Q1 2023

Apr 20, 2023

SELL
$335.35 - $386.06 $1,006 - $1,158
-3 Reduced 0.52%
577 $205,000
Q4 2022

Jan 25, 2023

BUY
$346.68 - $397.58 $201,074 - $230,596
580 New
580 $0
Q2 2018

Aug 10, 2018

SELL
$133.4 - $158.13 $407,803 - $483,403
-3,057 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$138.75 - $176.72 $199,106 - $253,593
-1,435 Reduced 31.95%
3,057 $431,000
Q4 2017

Feb 05, 2018

SELL
$135.02 - $162.6 $14,852 - $17,886
-110 Reduced 2.39%
4,492 $701,000
Q3 2017

Nov 03, 2017

BUY
$146.0 - $161.87 $671,892 - $744,925
4,602
4,602 $707,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.